Key result
This review summarizes current knowledge regarding the mechanisms involved in right ventricular remodeling and functional alteration in patients with systemic sclerosis.
Answers are grounded in this paper and cite their sources.
Early detection of right ventricular dysfunction and remodeling in scleroderma patients using modern imaging tools may allow for specific therapeutic measures before the onset of pulmonary arterial hypertension.
Scleroderma, known also as systemic sclerosis (SSc), is a severe disease associated with high mortality rates, and right ventricular (RV) remodeling and dysfunction, along with pulmonary artery hypertension (PAH), are among the most important internal organ manifestations of this disease. PAH has a higher prevalence in patients with SSc compared to the general population and represents a significant predictor of mortality in SSc. In patients with SSc, the morphological remodeling and alteration of RV function begin even before the setting of PAH and lead to development of a specific adaptive pattern of the RV which is different from the one recorded in patients with IAPH. These alterations cause worse outcomes and increased mortality rates in SSc patients. Early detection of RV dysfunction and remodeling is possible using modern imaging tools currently available and can indicate the initiation of specific therapeutic measures before installation of PAH. The aim of this review is to summarize the current knowledge related to mechanisms involved in the remodeling and functional alteration of the RV in SSc patients.
No takes yet. Share an insight, caveat, or question.
Cucuruzac et al. (2018) conducted a review in Scleroderma (systemic sclerosis). This review summarizes current knowledge regarding the mechanisms involved in right ventricular remodeling and functional alteration in patients with systemic sclerosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: